Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease
Authors:
- 26 June 2013
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 22 (10) , 1229-1242
Abstract
(2013). Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease. Expert Opinion on Investigational Drugs: Vol. 22, No. 10, pp. 1229-1242. doi: 10.1517/13543784.2013.812631Keywords
This publication has 88 references indexed in Scilit:
- Pathology and pathogenesis of vascular cognitive impairment—a critical updateFrontiers in Aging Neuroscience, 2013
- Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy SeriesArchives of Neurology, 2012
- Effect of Antihypertensive Therapy on Cognitive Function in Early Executive Cognitive Impairment: A Double-blind Randomized Clinical TrialArchives of internal medicine (1960), 2012
- Direct Stimulation of Angiotensin II Type 2 Receptor Enhances Spatial MemoryJournal of Cerebral Blood Flow & Metabolism, 2011
- The Association Between Blood Pressure and Incident Alzheimer DiseaseEpidemiology, 2011
- Identification and characterization of a functional mitochondrial angiotensin systemProceedings of the National Academy of Sciences, 2011
- Toward a pathological definition of vascular dementiaJournal of the Neurological Sciences, 2010
- Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With HypertensionArchives of internal medicine (1960), 2009
- Renin‐angiotensin system revisitedJournal of Internal Medicine, 2008
- Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trialThe Lancet Neurology, 2008